Retraction notice to "Corrigendum to 'Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer' [International Journal of Biological Macromolecules 248 (2023) 125782]"

Int J Biol Macromol. 2025 Jan 4:293:138913. doi: 10.1016/j.ijbiomac.2024.138913. Online ahead of print.
No abstract available

Publication types

  • Retraction Notice